NEJM reports case of eyelid hemangioma with bloody tears

Published On 2018-11-01 12:30 GMT   |   Update On 2018-11-01 12:30 GMT

Italy: An interesting case of eyelid hemangioma with bloody tears was reported in The New England Journal of Medicine. Alessandra Di Maria, from Humanitas Clinical and Research Center and Fausto Famà, University Hospital Messina, Italy describe the case of a 52-year-old man presented to the emergency department with painless, blood tears from both the eyes. The bleeding had begun spontaneously approximately 2 hours earlier, had lasted a few minutes, and had recurred just before presentation. He reported no orbital, ocular, or nasal trauma and no history of bloody tears, epistaxis, gingival bleeding, or easy bruising.


The patient was taking captopril for mild hypertension, and his blood pressure at examination was normal. The clinical examination revealed slight conjunctival hyperemia without periorbital or palpebral edema. The patient had normal vision and extraocular movements. The bloody appearance of the tears stopped spontaneously within 1 hour after the presentation. Slit-lamp examination revealed hemangiomas on the inside of both eyelids.


Hemolacria is a rare condition that is characterized by the presence of blood in the tears. Bleeding associated with tears can occur in the context of infection, inflammation, or trauma to the eye or surrounding structures, vascular tumors of the eye or surrounding structures, or retrograde epistaxis.


For the eyelid hemangiomas, the patient began using timolol ophthalmic drops. At 1 year of follow-up, the patient had had no further episodes of bloody tears.

Tags:    
Article Source : With inputs from NEJM

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News